Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. It is used in people with type 2 diabetes.Controlling high blood. Drug class: Meglitinides. Medically reviewed by Philip Thornton, DipPharm. Last updated on Jul 9, 2020. Uses; Warnings; Dosage; What to avoid; Side effects; Interactions ; What is Prandin? Prandin (repaglinide) is an oral diabetes medicine that helps control blood sugar levels by causing the pancreas to produce insulin. Prandin is used together with diet and exercise to improve blood sugar. Repaglinide is mainly metabolized by the liver, and less than 10% of its metabolites are excreted by the kidneys. Thus its use in ESRD patients may be allowed with meticulous care and with regard to the risk of hypoglycemia. Lactic acidosis is a rare but potentially fatal complication of metformin, so the administration of this drug should also be avoided in CRF patients. Insulin can be. Drug Listing. Most prescription and non-prescription (over-the-counter) drugs are covered at no cost, or low cost to you, as long as your doctor orders them and they are listed on our Formulary. A committee of doctors and pharmacists reviews the list of drugs on our formulary to make sure that the drugs are safe and effective. If your doctor decides that you must have a drug that is not. The drug's effect on the QT interval is increased in the setting of liver dysfunction; thus it is contraindicated in persons with mild to severe liver disease. Side effects. The most common side effects are dizziness (11.5%) and constipation (10.9%). Other side effects include headache and nausea. Drug interactions. Ranolazine is metabolized mainly by the CYP3A enzyme. It also inhibits another. Drug Name Avg. Rating Reviews; Prandin Generic name: repaglinide: 9.3. 6 reviews: Starlix Generic name: nateglinide: 7.0. 1 review: For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). See Also. Medical conditions associated with meglitinides: Diabetes, Type 2; Further. TD administration: 100-200 mcg/day patch q7Days; initiate 0.1-0.3 mg PO q4-6hr for first 2 days to allow for adequate drug levels. Postherpetic Neuralgia (Off-label) PO administration: 0.1 mg q12hr. Psychosis (Off-label) PO administration: 0.4-1.4 mg/day in divided doses. Pheochromocytoma Diagnosis (Off-label) Clonidine suppression testing: 0.3 mg PO for 60-80 kg patient; obtain blood sample 3. Prandimet ® (as a combination product containing Metformin, Repaglinide)see Repaglinide Prandimet ® (as a combination product containing Metformin, Repaglinide) see Metformin Prandin ® see Repaglinide Repaglinide is used to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Repaglinide helps your body regulate the amount of glucose (sugar) in your blood. It decreases the amount of glucose by stimulating the pancreas to release insulin. Over time, people who have diabetes and high blood sugar can. Drug Administration (FDA) may not be covered upon release specific prescription benefit plan design may not cover certain to the market. products or categories, regardless of their appearance in this • For specific information regarding your prescription benefit document. Products recently approved by the FDA may not be coverage and copay1 information, please visit Caremark.com covered upon.